REGiMMUNE starts Phase II study of RGI-2001 for treatment of Graft-versus-host disease | #gvhd Clinical Trials Market
REGiMMUNE starts Phase II study of RGI-2001 for treatment of Graft-versus-host disease | #gvhd Clinical Trials Market
Biogen begins ISIS-SOD1Rx Phase I/II trial to treat ALS | #superoxide Dismutase drugs development Market
As Efzofitimod moves closer to clinical approval, what is the likelihood that the drug will be approved? | #sarcoidosis market
Syncrude Athabasca Oil Sands Mine, Alberta | #japan Crude Oil Refinery Market
How can IOT Market mitigate the impact of droughts on harvests? | #iot Market